Home » Topics » Disease categories and therapies » Infection

Infection
RSS

U.S. and Italian researchers team up to design new beta-lactamase inhibitors

July 26, 2000

Arrow Therapeutics and Triangle Pharmaceuticals establish collaboration for antiviral agents

July 25, 2000

Numerous antiherpesvirus agents in development at AHP

July 24, 2000

Telithromycin at standard and high doses does not prolong Q-T interval in humans

July 24, 2000

Antimicrobial hygromycin A derivatives in development at Pfizer

July 21, 2000

Complete inhibition of HCMV replication obtained on combination regimens

July 21, 2000

Alcon to develop drop formulation of moxifloxacin

July 21, 2000

Inhibitors of fungal chitin synthase a focus of research at Roche

July 20, 2000

NewBiotics' NB-2001 may eliminate resistant bacteria

July 19, 2000

Abbott's novel antifungal lipopeptide characterized in vitro

July 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...